1. Self-efficacy expectancies may increase by the "Chronic Disease Self-Management Program" in congestive heart failure intervention patients as compared to controls; 2. These higher levels of self-efficacy expectancies contribute to…
ID
Bron
Verkorte titel
Aandoening
Congestive heart failure
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Self-efficacy expectancies:<br>
a. General expectancies: General Self-Efficacy Scale (GSES);<br>
b. Cardiac expectancies by scale Sullivan et al. (1998);<br>
2. Perceived control/ mastery by Mastery scale (Pearlin & Schooler 1978).
Achtergrond van het onderzoek
This study comprises both an effect and a process evaluation of the into Dutch translated "Chronic Disease Self-Management Program" among congestive heart failure patients. The self-management course, developed by Lorig and colleagues (Stanford University), has been broadly evaluated and implemented in the USA. In the present study the course is led by 2 trained course leaders (nurse specialist + congestive heart failure patient). Effectiveness of the Dutch version among congestive heart failure patients is assessed in a RCT-design with 1-year follow-up.
Doel van het onderzoek
1. Self-efficacy expectancies may increase by the "Chronic Disease Self-Management Program" in congestive heart failure intervention patients as compared to controls;
2. These higher levels of self-efficacy expectancies contribute to health behavior, and will decrease demoralization (depressive symptoms, feelings of anxiety) and functional disability and increase levels of quality of life.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
1. Patients in the intervention group attend a protocolled self-management group course (6 weekly sessions of 2,5 hours per session);
2. Patients assigned to the control group received usual care.
Publiek
P.O. Box 616
Esther S.T.F. Smeulders
Maastricht 6200 MD
The Netherlands
+31 (0)43 3884183
E.Smeulders@ZW.unimaas.nl
Wetenschappelijk
P.O. Box 616
Esther S.T.F. Smeulders
Maastricht 6200 MD
The Netherlands
+31 (0)43 3884183
E.Smeulders@ZW.unimaas.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Extent of congestive heart failure (CHF): systolic CHF; LVEF<40% (NYHA 2-3) or diastolic CHF (NYHA 2-3 + additional hospital admission ‘Decompensatio Cordis’ after being diagnosed with CHF);
2. Diagnosis CHF at least 3 months ago to include only stable patients (an additional 3 months before the start of the intervention sums up to 6 months);
3. Ability to understand/write/speak Dutch.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Participation in other scientific research.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL427 |
| NTR-old | NTR467 |
| Ander register | : NHS, nr. 2002B005 |
| ISRCTN | ISRCTN88363287 |